天麻素制剂临床应用中国专家共识(2021)

2021-05-28 中华老年医学杂志.2021.40(4):407-415.

天麻素制剂在治疗眩晕、头痛以及心脑血管病等疾病中的临床应用广泛，受到多个指南及专家共识的推荐，它既可以作为单用治疗药物，也可以与其他药物联合应用，且不良反应少、安全性较好，有较高的临床应用价值。本共识

中文标题：

发布机构：

发布日期：

2021-05-28

简要介绍：

天麻素制剂在治疗眩晕、头痛以及心脑血管病等疾病中的临床应用广泛，受到多个指南及专家共识的推荐，它既可以作为单用治疗药物，也可以与其他药物联合应用，且不良反应少、安全性较好，有较高的临床应用价值。本共识旨在总结天麻素制剂在眩晕、头面痛、心脑血管疾病、焦虑抑郁等疾病中的临床应用情况，规范天麻素制剂的临床应用，为综合医院医务人员和基层医务工作者临床应用天麻素制剂提供循证专家共识建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=32bd11c00211867a, title=天麻素制剂临床应用中国专家共识(2021), enTitle=, guiderFrom=中华老年医学杂志.2021.40(4):407-415., authorId=0, author=, summary=天麻素制剂在治疗眩晕、头痛以及心脑血管病等疾病中的临床应用广泛，受到多个指南及专家共识的推荐，它既可以作为单用治疗药物，也可以与其他药物联合应用，且不良反应少、安全性较好，有较高的临床应用价值。本共识, cover=https://img.medsci.cn/2021629/1624978465858_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri May 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>天麻素制剂在治疗眩晕、头痛以及心脑血管病等疾病中的临床应用广泛，受到多个指南及专家共识的推荐，它既可以作为单用治疗药物，也可以与其他药物联合应用，且不良反应少、安全性较好，有较高的临床应用价值。本共识旨在总结天麻素制剂在眩晕、头面痛、心脑血管疾病、焦虑抑郁等疾病中的临床应用情况，规范天麻素制剂的临床应用，为综合医院医务人员和基层医务工作者临床应用天麻素制剂提供循证专家共识建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=113192, tagName=天麻)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12590, guiderKeyword=眩晕, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13004, appHits=155, showAppHits=0, pcHits=799, showPcHits=12848, likes=3, shares=11, comments=8, approvalStatus=1, publishedTime=Tue Jun 29 23:46:32 CST 2021, publishedTimeString=2021-05-28, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Tue Jun 29 22:54:41 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Thu Jan 04 18:30:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=天麻素制剂临床应用中国专家共识(2021).pdf)])

天麻素制剂临床应用中国专家共识(2021).pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1179434, encodeId=c51011e9434bf, content=好吧！手残！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Fri Dec 31 23:00:00 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083583, encodeId=1b34108358362, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03d85623379, createdName=ms5000001358143490, createdTime=Thu Dec 23 16:23:45 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056182, encodeId=da191056182f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd35325510, createdName=148b9f9cm80暂无昵称, createdTime=Wed Sep 29 18:31:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012409, encodeId=348b10124091a, content=积分不够，想下指南不容易, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:30 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005430, encodeId=9f551005430ad, content=怎么兑换积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700e5545582, createdName=Canopy2, createdTime=Thu Aug 05 18:54:02 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
2021-12-31 最后一支肾上腺素

好吧！手残！

69 0
[GetPortalCommentsPageByObjectIdResponse(id=1179434, encodeId=c51011e9434bf, content=好吧！手残！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Fri Dec 31 23:00:00 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083583, encodeId=1b34108358362, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03d85623379, createdName=ms5000001358143490, createdTime=Thu Dec 23 16:23:45 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056182, encodeId=da191056182f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd35325510, createdName=148b9f9cm80暂无昵称, createdTime=Wed Sep 29 18:31:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012409, encodeId=348b10124091a, content=积分不够，想下指南不容易, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:30 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005430, encodeId=9f551005430ad, content=怎么兑换积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700e5545582, createdName=Canopy2, createdTime=Thu Aug 05 18:54:02 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
2021-12-23 ms5000001358143490

牛

99 0
[GetPortalCommentsPageByObjectIdResponse(id=1179434, encodeId=c51011e9434bf, content=好吧！手残！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Fri Dec 31 23:00:00 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083583, encodeId=1b34108358362, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03d85623379, createdName=ms5000001358143490, createdTime=Thu Dec 23 16:23:45 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056182, encodeId=da191056182f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd35325510, createdName=148b9f9cm80暂无昵称, createdTime=Wed Sep 29 18:31:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012409, encodeId=348b10124091a, content=积分不够，想下指南不容易, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:30 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005430, encodeId=9f551005430ad, content=怎么兑换积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700e5545582, createdName=Canopy2, createdTime=Thu Aug 05 18:54:02 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
2021-09-29 148b9f9cm80暂无昵称

学习了

100 0
[GetPortalCommentsPageByObjectIdResponse(id=1179434, encodeId=c51011e9434bf, content=好吧！手残！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Fri Dec 31 23:00:00 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083583, encodeId=1b34108358362, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03d85623379, createdName=ms5000001358143490, createdTime=Thu Dec 23 16:23:45 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056182, encodeId=da191056182f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd35325510, createdName=148b9f9cm80暂无昵称, createdTime=Wed Sep 29 18:31:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012409, encodeId=348b10124091a, content=积分不够，想下指南不容易, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:30 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005430, encodeId=9f551005430ad, content=怎么兑换积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700e5545582, createdName=Canopy2, createdTime=Thu Aug 05 18:54:02 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
2021-08-28 lotus蓉

积分不够，想下指南不容易

99 0
[GetPortalCommentsPageByObjectIdResponse(id=1179434, encodeId=c51011e9434bf, content=好吧！手残！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Fri Dec 31 23:00:00 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083583, encodeId=1b34108358362, content=牛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03d85623379, createdName=ms5000001358143490, createdTime=Thu Dec 23 16:23:45 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056182, encodeId=da191056182f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bd35325510, createdName=148b9f9cm80暂无昵称, createdTime=Wed Sep 29 18:31:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012409, encodeId=348b10124091a, content=积分不够，想下指南不容易, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:30 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005430, encodeId=9f551005430ad, content=怎么兑换积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700e5545582, createdName=Canopy2, createdTime=Thu Aug 05 18:54:02 CST 2021, time=2021-08-05, status=1, ipAttribution=)]
2021-08-05 Canopy2

怎么兑换积分

82 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

神经科指南

天麻素制剂临床应用中国专家共识(2021)

拓展阅读

科室

工具

服务